EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The glycolytic enzyme PFKFB3 drives kidney fibrosis through promoting histone lactylation-mediated NF-κB family activation

Yating Wang, Hongyu Li, Simin Jiang, Dongying Fu, Xiaohui Lu, Miaoqing Lu, Yi Li, Dan Luo, Kefei Wu, Yiping Xu, Guanglan Li, Yi Zhou und 4 weitere

Kidney International · 2024-08 · 106 (2) · 226-240

DOI: 10.1016/j.kint.2024.04.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney International, 2024-08. Verfasst von Yating Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; NHC Key Laboratory of Clinical Nephrology (Sun Yat…. Hauptthemen laut MEDLINE: Phosphofructokinase-2, Fibrosis, Renal Insufficiency, Chronic, Glycolysis. Die Arbeit wurde bisher 220-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Persistently elevated glycolysis in kidney has been demonstrated to promote chronic kidney disease (CKD). However, the underlying mechanism remains largely unclear. Here, we observed that 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3), a key glycolytic enzyme, was remarkably induced in kidney proximal tubular cells (PTCs) following ischemia-reperfusion injury (IRI) in mice, as well as in multiple etiologies of patients with CKD. PFKFB3 expression was positively correlated with the severity of kidney fibrosis. Moreover, patients with CKD and mice exhibited increased urinary lactate/creatine levels and kidney lactate, respectively. PTC-specific deletion of PFKFB3 significantly reduced kidney lactate levels, mitigated inflammation and fibrosis, and preserved kidney function in the IRI mouse model. Similar protective effects were observed in mice with heterozygous deficiency of PFKFB3 or those treated with a PFKFB3 inhibitor. Mechanistically, lactate derived from PFKFB3-mediated tubular glycolytic reprogramming markedly enhanced histone lactylation, particularly H4K12la, which was enriched at the promoter of NF-κB signaling genes like Ikbkb, Rela, and Relb, activating their transcription and facilitating the inflammatory response. Further, PTC-specific deletion of PFKFB3 inhibited the activation of IKKβ, I κ B α, and p65 in the IRI kidneys. Moreover, increased H4K12la levels were positively correlated with kidney inflammation and fibrosis in patients with CKD. These findings suggest that tubular PFKFB3 may play a dual role in enhancing NF-κB signaling by promoting both H4K12la-mediated gene transcription and its activation. Thus, targeting the PFKFB3-mediated NF-κB signaling pathway in kidney tubular cells could be a novel strategy for CKD therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphofructokinase-2FibrosisRenal Insufficiency, ChronicGlycolysisDisease Models, AnimalReperfusion InjuryNF-kappa BHistonesAnimalsHumansMiceMaleMice, KnockoutMice, Inbred C57BLSignal TransductionKidney Tubules, ProximalLactic AcidKidney

Stichwörter der Autor:innen

NF-κB signalingPFKFB3histone lactylationrenal fibrosis

Substanzen

Phosphofructokinase-2PFKFB3 protein, mousePFKFB3 protein, humanNF-kappa BHistonesLactic Acid

Autor:innen und Institutionen

  • Department of Nephrology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; NHC Key Laboratory of Clinical Nephrology (Sun Yat-sen University) and Guangdong Provincial Key Laboratory of Nephrology…
  • NHC Key Laboratory of Clinical Nephrology (Sun Yat-sen University) and Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China; Department of Pathology, the First Affiliated Hospital, Sun Yat-sen University,…
  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Bas…

Förderung

  • Natural Science Foundation of Guangdong Province
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Wang, Y., Li, H., Jiang, S., Fu, D., Lu, X., Lu, M., Li, Y., Luo, D., Wu, K., Xu, Y., Li, G., Zhou, Y., Zhou, Y., Chen, W., Liu, Q., & Mao, H. (2024). The glycolytic enzyme PFKFB3 drives kidney fibrosis through promoting histone lactylation-mediated NF-κB family activation. Kidney International, 106(2), 226-240. https://doi.org/10.1016/j.kint.2024.04.016

Vancouver

Wang Y, Li H, Jiang S, Fu D, Lu X, Lu M, et al. The glycolytic enzyme PFKFB3 drives kidney fibrosis through promoting histone lactylation-mediated NF-κB family activation. Kidney International. 2024;106(2):226-240. doi:10.1016/j.kint.2024.04.016

BibTeX
@article{Wang2024,
  author = {Wang, Yating and Li, Hongyu and Jiang, Simin and Fu, Dongying and Lu, Xiaohui and Lu, Miaoqing and Li, Yi and Luo, Dan and Wu, Kefei and Xu, Yiping and Li, Guanglan and Zhou, Yi and Zhou, Yiming and Chen, Wei and Liu, Qinghua and Mao, Haiping},
  title = {The glycolytic enzyme PFKFB3 drives kidney fibrosis through promoting histone lactylation-mediated NF-κB family activation},
  journal = {Kidney International},
  year = {2024},
  volume = {106},
  number = {2},
  pages = {226--240},
  doi = {10.1016/j.kint.2024.04.016}
}
Kostenlos starten →